Heart Failure

Featured Article

Affordable Care Act Repeal May Undo Reduced Heart Transplant Disparities

Affordable Care Act Repeal May Undo Reduced Heart Transplant Disparities

Heart transplant disparities have improved since the adoption of the Affordable Care Act; if the law is repealed, experts fear these disparities will return.

Latest Features

Preventing Heart Failure One Risk Factor at a Time

Preventing Heart Failure One Risk Factor at a Time

Avoiding 3 major risk factors for heart failure—hypertension, diabetes, and obesity—may reduce the likelihood of heart failure development.

Hope for Heart Failure in Thyroid Hormone Therapy

Hope for Heart Failure in Thyroid Hormone Therapy

Subclinicial hypothyroidism has been associated with an increased risk for coronary heart disease events and mortality.

Premature Ventricle Contractions in Heart Failure: A Closer Examination

Premature Ventricle Contractions in Heart Failure: A Closer Examination

A primer on premature ventricle contractions with commentary from 2 arrhythmic/heart failure experts.

ARVD/Cardiomyopathy: Interview with Expert Hugh Calkins, MD

ARVD/Cardiomyopathy: Interview with Expert Hugh Calkins, MD

While ARVD/C management has greatly improved, more precautions—particularly in genetic testing and exercise—need to be taken.

Clinician Viewpoints on the "2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure"

Clinician Viewpoints on the "2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure"

Drs Tauras and Patel from Montefiore Medical Center in the Bronx, New York weigh in on what the new heart failure therapeutic guidelines mean for practicing clinicians.

Managing Cardiovascular Complications of Oncology Treatment

Managing Cardiovascular Complications of Oncology Treatment

Clinicians seek stronger collaboration between cardiology and oncology as well as evidence-based treatment guidelines.

Ixmyelocel-T Cell-Based Therapy Reduced Cardiac Events in Heart Failure

Ixmyelocel-T Cell-Based Therapy Reduced Cardiac Events in Heart Failure

Ixmyelocel-T therapy reduced clinical cardiac events and improved patient outcomes.

Better Late Than Never: Exercise as Primary and Secondary Prevention in CVD

Better Late Than Never: Exercise as Primary and Secondary Prevention in CVD

Exercise's potential positive effects on cardiovascular disease and heart failure may be possible regardless of frequency and time of initiation.

Heart Failure Patients Rarely Use Evidence-Based Alternative Treatments

Heart Failure Patients Rarely Use Evidence-Based Alternative Treatments

Patients with heart failure rarely use evidence-based alternative treatments such as yoga or massage, to manage their comorbid chronic pain.

Mitral Valve Repair: The Evolution of Transcatheter Implantation

Mitral Valve Repair: The Evolution of Transcatheter Implantation

Repairing mitral regurgitation via transcatheter MitraClip has become a promising therapeutic option for high surgical risk patients.

Latest News

Can Beta-Blockers Reduce Mortality in Acute Myocardial Infarction Without Heart Failure?

Can Beta-Blockers Reduce Mortality in Acute Myocardial Infarction Without Heart Failure?

In patients with acute myocardial infarction without heart failure, beta-blockers did not reduce mortality risk at 1 year.

Subclinical Myocardial Damage in Obesity May Be Mitigated by Physical Activity

Subclinical Myocardial Damage in Obesity May Be Mitigated by Physical Activity

Individuals who had the lowest levels of recommended physical activity had elevated levels of high-sensitivity cardiac troponin T.

Exercise Capacity in Heart Failure With Reduced Ejection Fraction Not Improved With Iron Supplementation

Exercise Capacity in Heart Failure With Reduced Ejection Fraction Not Improved With Iron Supplementation

Patients with heart failure with reduced ejection fraction and iron deficiency do not benefit from iron supplementation.

Acute Heart Failure Mortality Increased With Morphine

Acute Heart Failure Mortality Increased With Morphine

Patients with acute heart failure who received intravenous morphine in the emergency department had higher mortality compared with patients who did not receive morphine.

Heart Failure Risk Increased With Fewer Menstrual Cycles

Heart Failure Risk Increased With Fewer Menstrual Cycles

Women with fewer menstrual cycles are at a higher risk for incident heart failure.

Ivabradine in Heart Failure With Preserved Ejection Fraction

Ivabradine in Heart Failure With Preserved Ejection Fraction

Ivabradine did not improve exercise capacity, diastolic function, or NT-proBNP levels in patients with heart failure with preserved ejection fraction.

Newly Diagnosed Atrial Fibrillation Benefits From Rivaroxaban, Dabigatran

Newly Diagnosed Atrial Fibrillation Benefits From Rivaroxaban, Dabigatran

Direct oral anticoagulation reduced the risk of congestive heart failure admissions and all-cause mortality in both genders.

Parenteral Nutrition in Comorbid Congestive Heart Failure Outcomes

Parenteral Nutrition in Comorbid Congestive Heart Failure Outcomes

Patients with comorbid congestive heart failure who received parenteral nutrition experienced increased negative outcomes in their hospital stay.

HIV Infection's Impact on HF: Reduced EF vs Preserved EF in ART

HIV Infection's Impact on HF: Reduced EF vs Preserved EF in ART

HIV poses higher risks of heart failure even at younger ages of infection, and 25% of all new cases in the United States occur in people between age 13 and 24.

Renin-Angiotensin System Inhibition Effect on Post-MI Mortality and New-Onset Atrial Fibrillation

Renin-Angiotensin System Inhibition Effect on Post-MI Mortality and New-Onset Atrial Fibrillation

Renin-angiotensin system inhibition was linked with a reduced 3-year risk of all-cause mortality in patients with congestive heart failure and atrial fibrillation.

Sign Up for Free e-Newsletters